| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.HUMPATH.2005.09.014 |
| P698 | PubMed publication ID | 16311121 |
| P50 | author | Tanri Shiozawa | Q115215703 |
| P2093 | author name string | Ikuo Konishi | |
| Hiroyasu Kashima | |||
| Tsutomu Miyamoto | |||
| Akihisa Suzuki | |||
| Miyuki Kurai | |||
| Yu-Zhen Feng | |||
| Hsien-Chang Shih | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1281-1288 | |
| P577 | publication date | 2005-12-01 | |
| P1433 | published in | Human Pathology | Q15756731 |
| P1476 | title | Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma | |
| P478 | volume | 36 |
| Q36297651 | Aurora A kinase expression is increased in leukemia stem cells, and a selective Aurora A kinase inhibitor enhances Ara-C-induced apoptosis in acute myeloid leukemia stem cells |
| Q52967182 | Aurora B expression and histone variant H1.4S27 phosphorylation are no longer coordinated during metaphase in aneuploid colorectal carcinomas |
| Q36215925 | Aurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells |
| Q54614871 | Aurora B kinase expression in laryngeal squamous cell carcinoma and its prognostic implications |
| Q53076735 | Aurora B kinase in Hodgkin lymphoma: immunohistochemical pattern of expression in neoplastic Hodgkin and Reed-Sternberg cells |
| Q35168142 | Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer. |
| Q37328115 | Aurora kinase inhibitor PHA-739358 suppresses growth of hepatocellular carcinoma in vitro and in a xenograft mouse model |
| Q42562915 | Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors. |
| Q37165838 | Aurora-A expression is independently associated with chromosomal instability in colorectal cancer |
| Q34603819 | Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer |
| Q34546309 | Aurora-B overexpression is correlated with aneuploidy and poor prognosis in non-small cell lung cancer |
| Q34460444 | Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers |
| Q27663716 | Discovery of imidazo[1,2-a]pyrazine-based Aurora kinase inhibitors |
| Q36410067 | Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment |
| Q53277143 | Evaluation of Aurora kinase inhibition as a new therapeutic strategy in anaplastic and poorly differentiated follicular thyroid cancer. |
| Q39961166 | Expression of Aurora A (but not Aurora B) is predictive of survival in breast cancer |
| Q61445872 | Expression of USP22 and the chromosomal passenger complex is an indicator of malignant progression in oral squamous cell carcinoma |
| Q34779117 | Gene Expression Analysis of Early Stage Endometrial Cancers Reveals Unique Transcripts Associated with Grade and Histology but Not Depth of Invasion |
| Q53187326 | High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer |
| Q43719036 | High expressions of histone methylation- and phosphorylation-related proteins are associated with prognosis of oral squamous cell carcinoma in male population of Taiwan |
| Q41561035 | High proliferation index, as determined by immunohistochemical expression of Aurora kinase B and geminin, indicates poor prognosis in neuroblastomas |
| Q41135024 | Histone-modifying genes as biomarkers in hepatocellular carcinoma |
| Q33962378 | Inhibition of Aurora-B suppresses HepG2 cell invasion and migration via the PI3K/Akt/NF-κB signaling pathway in vitro |
| Q35944474 | Knockdown of Aurora-B inhibits the growth of non-small cell lung cancer A549 cells |
| Q45888331 | Let7a inhibits the growth of endometrial carcinoma cells by targeting Aurora‐B |
| Q41136238 | MicroRNA let-7b regulates genomic balance by targeting Aurora B kinase |
| Q38115166 | Mitosis as an anti-cancer drug target |
| Q38030445 | Mitotic failures in cancer: Aurora B kinase and its potential role in the development of aneuploidy |
| Q47547178 | Network analysis revealed aurora kinase dysregulation in five gynecological types of cancer |
| Q42225405 | Nuclear Aurora B and cytoplasmic Survivin expression is involved in lymph node metastasis of colorectal cancer |
| Q35008444 | Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients |
| Q34632923 | Phase I dose escalation study of MK-0457, a novel Aurora kinase inhibitor, in adult patients with advanced solid tumors |
| Q39288016 | Preclinical Characterization of ABT-348, a Kinase Inhibitor Targeting the Aurora, Vascular Endothelial Growth Factor Receptor/Platelet-Derived Growth Factor Receptor, and Src Kinase Families |
| Q39824320 | Preclinical characterization of Aurora kinase inhibitor R763/AS703569 identified through an image-based phenotypic screen |
| Q27024067 | Prognostic value of Aurora kinase A (AURKA) expression among solid tumor patients: a systematic review and meta-analysis |
| Q38101000 | Regulation of chromatin structure via histone post-translational modification and the link to carcinogenesis. |
| Q38777275 | Significance of AZD1152 as a potential treatment against Aurora B overexpression in acute promyelocytic leukemia |
| Q39019773 | Structural studies of B-type Aurora kinase inhibitors using computational methods |
| Q64907363 | Synthesis and biological evaluation of chalcone-linked pyrazolo[1,5-a]pyrimidines as potential anticancer agents. |
| Q37167047 | The potential role of Aurora kinase inhibitors in haematological malignancies |
| Q38362213 | The role of microRNAs in the pathogenesis of endometrial cancer: a systematic review. |
| Q89666682 | Triple-high expression of phosphatase and tensin homolog (PTEN), estrogen receptor (ER) and progesterone receptor (PR) may predict favorable prognosis for patients with Type I endometrial carcinoma |
| Q39762903 | p53 is critical for the Aurora B kinase inhibitor-mediated apoptosis in acute myelogenous leukemia cells |
Search more.